Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Bone Biologics Corp. (BBLG : NSDQ)
 
 • Company Description   
Bone Biologics Corp. is a developer of orthobiologic products for spine fusion markets. Bone Biologics Corp. is based in BURLINGTON, Mass.

Number of Employees: 2

 
 • Price / Volume Information   
Yesterday's Closing Price: $2.94 Daily Weekly Monthly
20 Day Moving Average: 1,480,199 shares
Shares Outstanding: 0.55 (millions)
Market Capitalization: $1.60 (millions)
Beta: 0.69
52 Week High: $22.20
52 Week Low: $2.87
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -38.36% -41.14%
12 Week -27.93% -39.18%
Year To Date -47.88% -51.03%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
2 BURLINGTON WOODS DRIVE SUITE 100
-
BURLINGTON,MA 01803
USA
ph: 781-552-4452
fax: -
jcain@allianceadvisors.com http://www.bonebiologics.com
 
 • General Corporate Information   
Officers
Jeffrey Frelick - Chief Executive Officer and President
Bruce Stroever - Chairman of the Board of Directors
Deina H. Walsh - Chief Financial Officer
Siddhesh Angle - Director
Phil Meikle - Director

Peer Information
- (-)
- (-)
- (-)
- (-)
- (-)
- (-)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED-BIOMED/GENE
Sector: Medical
CUSIP: 098070600
SIC: 3842
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/25
Next Expected EPS Date: 08/08/25
Share - Related Items
Shares Outstanding: 0.55
Most Recent Split Date: 6.00 (0.17:1)
Beta: 0.69
Market Capitalization: $1.60 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.53 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-1.93 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/08/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 0.55
Price/Cash Flow: -
Price / Sales: -
EPS Growth
vs. Year Ago Period: 75.57%
vs. Previous Quarter: -%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -%
ROE
06/30/25 - -
03/31/25 - -130.21
12/31/24 - -118.67
ROA
06/30/25 - -
03/31/25 - -119.39
12/31/24 - -109.95
Current Ratio
06/30/25 - -
03/31/25 - 12.60
12/31/24 - 10.21
Quick Ratio
06/30/25 - -
03/31/25 - 12.60
12/31/24 - 10.21
Operating Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Net Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Pre-Tax Margin
06/30/25 - -
03/31/25 - -
12/31/24 - -
Book Value
06/30/25 - -
03/31/25 - 5.34
12/31/24 - 8.39
Inventory Turnover
06/30/25 - -
03/31/25 - -
12/31/24 - -
Debt-to-Equity
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
Debt-to-Capital
06/30/25 - -
03/31/25 - 0.00
12/31/24 - 0.00
 

Powered by Zacks Investment Research ©